Daily non-political popular news in brief.
Fosrenol does not further impact cognitive function deterioration in CKD Stage 5 patients
10-18-2006 · EurekAlert!Newly published data from a large, two-year trial in the November Kidney International report on the effects of chronic kidney disease on cognitive function in CKD Stage 5 patients with hyperphosphatemia (high serum phosphorus levels in the blood), treated with phosphate binder therapy. This study is particularly relevant, as there is evidence that individuals with reduced renal function experience a significantly greater decline in cognitive function compared to those with normal renal function.
Read more »
Keywords: fosrenol, further, impact, cognitive, function, deterioration, ckd, stage, patients, patient
« Previous | Next »
Similar news on "Fosrenol does not further impact cognitive function deterioration in CKD Stage 5 patients":
- Fosrenol data show evidence of trends towards improved bone formation in CKD stage 5 patients
11-17-2006 · EurekAlert!
Treatment with the phosphate binder Fosrenol, lanthanum carbonate, was associated with slight improvements in bone formation in chronic kidney disease stage 5 patients with high phosphorus levels in the blood, according to long-term data presented at the American Society of Nephrology meeting. Additional studies presented at ASN document the efficacy and safety of the reformulated and higher-dose FOSRENOL tablets. Of the approximately 20 million Americans who have some form of kidney disease, more than 530,000 have developed CKD Stage 5.
Similar news · Read more »
- Sexual function affected by stem cell transplant according to long-term study
09-18-2007 · EurekAlert!
A long-term study found that a type of stem cell transplant used for patients with life-threatening diseases results in decreased sexual function and activity for recipients. Further, males are likely to recover from these changes over time, while the sexuality of female patients remains compromised. In addition, neither male nor female long-term cancer survivors regained levels of sexual activity and function equal to those of their peers who have not had cancer.
Similar news · Read more »
- Chemo drugs for treating breast cancer may cause changes in cognitive function
10-27-2006 · EurekAlert!
A new study investigating the effects of chemotherapy on cognitive function in mice has confirmed what many cancer patients receiving treatment have often complained about -- a decline in their memory and other cognitive functions, sometimes characterized as "chemobrain."
Similar news · Read more »
- Ibuprofen restores learning ability in rats with liver failure
08-01-2007 · EurekAlert!
Cognitive impairment is one of the neurological effects in patients with hepatic encephalopathy (abnormal brain function due to severe liver disease). For the first time, a new study showed that treatment with an anti-inflammatory improves cognitive function in rats induced with chronic liver failure.
Similar news · Read more »
- Study shows cognitive decline is often undetected
10-27-2006 · EurekAlert!
Many patients over the age of 65 who are hospitalized with an acute illness experience a subtle change in their cognitive ability that often goes undiagnosed, untreated and under-reported. As a result, a patient's ability to make decisions about his or her medical treatment may be negatively impacted.
Similar news · Read more »
- Penn researchers pinpoint the brain waves that distinguish false memories from real ones
10-23-2007 · EurekAlert!
For the first time, researchers at the University of Pennsylvania are able to pinpoint brain waves that distinguish true from false memories, providing a better understanding of how memory works and creating a new strategy to help epilepsy patients retain cognitive function.
Similar news · Read more »
- Obesity adds to the quality of life burden of rheumatoid arthritis
06-14-2007 · EurekAlert!
The global obesity epidemic was issued with a further health warning today -- that obesity exacerbates the quality of life of patients with rheumatoid arthritis. New data presented at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain, shows that RA in obese patients is associated with worse quality of life outcomes on four key levels: pain, fatigue, physical function and overall utility scores.
Similar news · Read more »
- Mix of compounds improves rodents' brain function
11-26-2007 · Massachusetts Institute of Technology (MIT)
MIT researchers have shown that a cocktail containing three compounds normally in the blood stream promotes growth of new brain connections and improves cognitive function in rodents. The treatment is now being tested in Alzheimer's patients.
Similar news · Read more »
- Clinical trials for diabetes drugs should measure outcomes important to patients
09-27-2007 · EurekAlert!
Most clinical trials for new diabetes drugs do not consider the impact medication will have on a patient's quality of life or other outcomes that are important to patients, such as the risk of developing complications associated with diabetes, according to a Mayo Clinic commentary in the current issue of the Lancet.
Similar news · Read more »
- Study finds limited options for backup HIV treatment in some developing countries
01-08-2007 · EurekAlert!
Thai researchers have discovered that patients who fail treatment with a commonly used, inexpensive, first-line antiretroviral therapy (ART) are also usually resistant to other, similar drugs, leaving progressively fewer options for replacement therapies. Since catching treatment failure early is key to preventing further resistance, this research, published in the February 1 issue of Clinical Infectious Diseases also argues for greater access in the developing world to tests that detect when the amount of virus in a patient's blood is increasing.
Similar news · Read more »
